- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/11 - DNA or RNA fragmentsModified forms thereof
Patent holdings for IPC class C12N 15/11
Total number of patents in this class: 18252
10-year publication summary
627
|
677
|
958
|
1035
|
1126
|
1209
|
1396
|
1450
|
1665
|
1195
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20015 |
514 |
Massachusetts Institute of Technology | 10080 |
318 |
The Broad Institute, Inc. | 1831 |
294 |
President and Fellows of Harvard College | 5993 |
272 |
Alnylam Pharmaceuticals, Inc. | 1142 |
194 |
Ionis Pharmaceuticals, Inc. | 878 |
189 |
University of Massachusetts | 2231 |
168 |
The Board of Trustees of the Leland Stanford Junior University | 6441 |
156 |
The General Hospital Corporation | 4751 |
151 |
Duke University | 3078 |
119 |
The Trustees of the University of Pennsylvania | 4328 |
114 |
CRISPR Therapeutics AG | 367 |
96 |
The Johns Hopkins University | 5689 |
92 |
University of Vienna | 112 |
88 |
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 310 |
88 |
Monsanto Technology LLC | 8303 |
87 |
Pioneer Hi-Bred International, Inc. | 6617 |
84 |
City of Hope | 996 |
84 |
Modernatx, Inc. | 1262 |
84 |
Flagship Pioneering Innovations VI, LLC. | 470 |
83 |
Other owners | 14977 |